Biolojic Design, Ltd. logo — Biolojic Design is a biopharmaceutical company dedicated to...

Biolojic Design, Ltd.

Biolojic Design is a biopharmaceutical company dedicated to the development of human antibody-based therapeutics for cancer and other diseases

Founded 2009 Israel Israel 70 employees Total: $3.95M AI, Biotechnology +1

General Information

Company Name Biolojic Design, Ltd.
Founded Year 2009
Location Israel Israel
Employees 70
Industries AI, Biotechnology, Pharmaceutical
Business Model B2B, Platform
Revenue Model Licensing, Performance Based, Project Based
Offices as of Oct 2026
Ness Ziona, Israel
Social

BounceWatch is an independent company data service, not affiliated with Biolojic Design, Ltd.. To contact Biolojic Design, Ltd., visit biolojic.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Biolojic Design, Ltd. compare?

A PDF of Biolojic Design, Ltd. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Biolojic Design, Ltd. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Product Launch Oct 06, 2026

Biolojic Design is taking an 18-year-old internal compound into patients for first-in-human studies, marking a significant step in its development.

About Biolojic Design, Ltd.

Biolojic Design, Ltd. is a pioneering biopharmaceutical company focused on developing innovative human antibody-based therapeutics aimed at treating cancer and other diseases. Founded in 2009, this Israeli startup leverages cutting-edge biotechnology and AI to target functional epitopes, addressing challenges where existing technologies fall short.

Having attracted a $3.95M late-stage venture capital investment in early 2021, Biolojic Design stands out for its robust potential in the biotechnology and pharmaceutical industries. Key investors such as OurCrowd, aMoon, and Winnovation uphold the company's vision and revolutionary approach.

The strategic location in Israel, a hub for innovation, further strengthens its competitive edge. In summary, Biolojic Design represents a compelling opportunity for investors interested in disruptive advancements in antibody-based therapies, with applications extending beyond oncology to diverse disease categories.

Business keywords: biopharmaceutical, antibody-based therapeutics, cancer treatment, AI-powered drug design, human antibodies, antibody engineering, functional epitopes, mAbs, Multibodies, multi-specific antibodies, biological targets, complex diseases, therapeutic development

Services & Products

Engineering epitope-specific and multibodies
Developing programmable antibodies
Leveraging AI and machine learning in drug design

Target Customers

Pharmaceutical Companies Biotechnology Researchers Healthcare Providers

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Late VC $3.95M 3
OurCrowd, aMoon +1
01 Jan 2021
Spinout Undisclosed 1
University Ventures
01 Dec 2009

Biolojic Design, Ltd. Alternatives & Competitors

View All Alternatives
Biolojic Design, Ltd. vs

Advancing antibody therapeutics for combating diseases and targeting various biological threats.

Seed
Biotechnology, Pharmaceutical
Biolojic Design, Ltd. vs
Genmab
Genmab Denmark

Differentiated human antibody therapeutics for the treatment of cancer

IPO
2981 employees
Biotechnology, Pharmaceutical
Biolojic Design, Ltd. vs
Apollomics
Apollomics United States

We are a biopharmaceutical company committed to the discovery and development of mono- and combinati...

Post-IPO Equity
26 employees
Biotechnology, Health Care

FAQ About Biolojic Design, Ltd.

Biolojic Design is a biopharmaceutical company dedicated to the development of human antibody-based therapeutics for cancer and other diseases
Biolojic Design, Ltd. was founded in 2009.
Biolojic Design, Ltd. is headquartered in Israel. As of Oct 2026, it also has offices in Ness Ziona, Israel.
Biolojic Design, Ltd. operates in AI, Biotechnology and Pharmaceutical. Its work centres on biopharmaceutical, antibody-based therapeutics, cancer treatment and AI-powered drug design. Its customers include Pharmaceutical Companies, Biotechnology Researchers and Healthcare Providers.
Biolojic Design, Ltd. has a B2B and Platform business model. Its revenue comes from Licensing, Performance Based and Project Based.
Biolojic Design, Ltd. has approximately 70 employees.
Biolojic Design, Ltd. has completed 2 funding rounds, raising a total of $3.95M.
Biolojic Design, Ltd. offers: Engineering epitope-specific and multibodies, Developing programmable antibodies, Leveraging AI and machine learning in drug design.
Top alternatives and competitors to Biolojic Design, Ltd. include Immunologix, Inc., Genmab, Apollomics, LabGenius Therapeutics, Antiverse. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Biolojic Design, Ltd. and Immunologix, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Biolojic Design, Ltd., https://bouncewatch.com/company/biolojic-design-ltd, updated 12 October 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes